We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£48.00
diplom.de Konstruktion und Charakterisierung rekombinanter bispezifischer Antikörper-Fragmente zur experimentellen Therapie der Hodgkinschen Krankheit
Price data checked 5 days ago
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£48 today · cheaper than every other day in the last 3 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 86 days · 86 data points (no recent data)
Price Distribution
Price distribution over 86 days • 1 price levels
Price Analysis
Most common price: £48 (86 days, 100.0%)
Price range: £48 - £48
Price levels: 1 different prices over 86 days
Product Specifications
- Brand
- diplom.de
- Format
- paperback
- ASIN
- 3838660048
- Domain
- Amazon UK
- Release Date
- 01 January 2002
- Listed Since
- 24 February 2009
Barcode
No barcode data available
Similar Products You Might Like
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in the United States
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in the United States
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in India
The 2023 Report on Non-Hodgkin Lymphoma Treatments: World Market Segmentation by City
The 2023-2028 World Outlook for Non-Hodgkin Lymphoma Treatments
Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)
Springer
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in India
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in the United States
Hodgkin's Lymphoma
IntechOpen
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Treatments
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in China
Requirements of T cell-driven Autoimmunity in Alymphoplastic Mice: Dissertation, University Zurich, Experimental Immunology, 2011
Südwestdeutscher Verlag für Hochschulschriften
Verteilungsmuster von Lymphozyten-Klassen und PHA-Reaktivität peripherer Lymphozyten bei Patienten mit malignen Tumoren: 3027 (Forschungsberichte des Landes Nordrhein-Westfalen, 3027)
VS Verlag für Sozialwissenschaften
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in China
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in China
Academic Press - Resistance to Anti-CD20 Antibodies Vol 2
Academic Press
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in Japan
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in Japan
The 2025-2030 World Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments
Diffuse Large B-Cell Lymphoma (DLBCL): Symptoms, Treatment & Prognosis
Innovations for Next-Generation Antibody-Drug Conjugates (Cancer Drug Discovery and Development)
Humana
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in Japan
Maladies Auto-immunes en service de médecine interne: Hôpital National de Niamey
ÉDITIONS UNIVERSITAIRES EUROPÉENNES